04:22 PM EST, 03/07/2025 (MT Newswires) -- Fouad Namouni, President, R&D, on March 05, 2025, sold 6,489 shares in Blueprint Medicines ( BPMC ) for $576,223. Following the Form 4 filing with the SEC, Namouni has control over a total of 75,781 common shares of the company, with 75,781 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1597264/000141588925007402/xslF345X05/form4-03072025_090326.xml